Status migrainosus in children and adolescents.
Data concerning status migrainosus in children and adolescents is sparse. The varied clinical presentations, diagnostic evaluation, and treatment modalities are discussed.
Akhtar
N D
ND
Department of Pediatric Neurology, The Cleveland Clinic Foundation, OH 44195, USA.
Murray
M A
MA
Rothner
A D
AD
D000293:Adolescent; D002648:Child; D003937:Diagnosis, Differential; D004087:Dihydroergotamine / Q000008:administration & dosage / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D008297:Male; D008614:Meperidine / Q000008:administration & dosage / Q000009:adverse effects; D008775:Methylprednisolone / Q000008:administration & dosage / Q000009:adverse effects; D008881:Migraine Disorders / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D018170:Sumatriptan / Q000008:administration & dosage / Q000009:adverse effects
D004087:Dihydroergotamine; D018170:Sumatriptan; D008614:Meperidine; D011239:Prednisolone; D008775:Methylprednisolone